We came across a bullish thesis on Novo Nordisk A/S on Value investing subreddit by Max-lindberg. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S’s share was trading at $49.35 as of November 28th. NVO’s trailing and forward P/E were 13.62 and 12.53 respectively according to Yahoo Finance.
Novo Nordisk (NVO), the Danish pharmaceutical leader behind Ozempic and Wegovy, has undergone a dramatic financial transformation driven by surging demand for its...
